recurrent ovarian germ cell tumor
Showing 1 - 25 of >10,000
Brenner Tumor, Malignant Ascites, Malignant Pleural Effusion Trial in United States (metformin HCl, , Chemotherapy)
Suspended
- Brenner Tumor
- +27 more
- metformin hydrochloride
- +2 more
-
Birmingham, Alabama
- +9 more
May 16, 2022
Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)
Completed
- Male Breast Cancer
- +7 more
- propranolol hydrochloride
- Correlative Studies
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 4, 2022
Adult Solid Tumor, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Philadelphia (PD-0332991)
Completed
- Adult Solid Tumor
- +38 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of The University of Pennsylvania
Feb 18, 2021
Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor, Stage IV Ovarian Epithelial Cancer Trial in Seattle
Completed
- Stage III Ovarian Epithelial Cancer
- +3 more
- pUMVC3-hIGFBP-2 multi-epitope plasmid DNA vaccine
- laboratory biomarker analysis
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Feb 22, 2021
Malignant Ovarian Germ Cell Tumors
Recruiting
- Fertility Issues
- observational study
-
Cairo, EgyptDepartment of Obstetrics & Gynecology
Jun 7, 2023
Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma, Ovarian Serous Cystadenocarcinoma Trial in Jacksonville,
Completed
- Ovarian Endometrioid Adenocarcinoma
- +8 more
- Everolimus
- +2 more
-
Jacksonville, Florida
- +1 more
Sep 28, 2020
Germ Cell Tumor, Seminoma, Non-seminomatous Germ Cell Tumor Trial in Indianapolis (Cabozantinib)
Recruiting
- Germ Cell Tumor
- +3 more
-
Indianapolis, IndianaIndiana University Melvin & Bren Simon Cancer Center
Nov 16, 2022
Germ Cell Tumor, Non-seminomatous Germ Cell Tumor, Ovarian Germ Cell Tumor Trial in Indianapolis (Etoposide)
Recruiting
- Germ Cell Tumor
- +2 more
-
Indianapolis, IndianaIndiana University Melvin & Bren Simon Cancer Center
Dec 20, 2022
Morbidity, Long-term Side Effects and Quality of Life in
Recruiting
- Germ Cell Tumor
-
Villejuif, FranceGustave Roussy
Jun 2, 2023
Germ Cell Tumors of the Central Nervous System
Recruiting
- Germ Cell Tumor of CNS
-
Beijing, ChinaSanbo Brain Hospital Capital Medical University
Apr 19, 2023
Pediatric Germ Cell Tumor Trial in Seoul (TIP treatment (paclitaxel/ifosfamide/cisplatin))
Recruiting
- Pediatric Germ Cell Tumor
- TIP treatment (paclitaxel/ifosfamide/cisplatin)
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Jul 8, 2022
Molecular Epidemiology of Pediatric Germ Cell Tumors
Recruiting
- Germ Cell Tumor
- +8 more
- Questionnaire Administration
- +3 more
-
Minneapolis, MinnesotaUniversity of Minnesota
Nov 22, 2022
Germ Cell Tumor and Testicular Tumor DNA Registry
Recruiting
- Germ Cell Tumor
- Testicular Tumor
- Questionnaires
- sample of blood or saliva
-
Basking Ridge, New Jersey
- +7 more
Jan 31, 2023
HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle
Active, not recruiting
- HER2-positive Breast Cancer
- +8 more
- pNGVL3-hICD vaccine
- +6 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Nov 1, 2022
CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)
Active, not recruiting
- Central Nervous System Tumor, Pediatric
- +8 more
- EGFR806-specific chimeric antigen receptor (CAR) T cell
-
Seattle, WashingtonSeattle Children's Hospital
Jan 18, 2023
Non-Seminomatous Germ Cell Tumor Trial in Villejuif (BEP Protocol, Dose-dense regimen, Early tumor resection or HD-CT)
Not yet recruiting
- Non-Seminomatous Germ Cell Tumor
- BEP Protocol
- +2 more
-
Villejuif, FranceGustave Roussy
Jan 27, 2023
Endothelial Function in Germ Cell Tumor Patients Treated With
Active, not recruiting
- Germ Cell Cancer
- Endo-PAT2000 testing
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 7, 2022
CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (HER2-specific chimeric antigen receptor (CAR) T cell)
Recruiting
- Central Nervous System Tumor, Pediatric
- +8 more
- HER2-specific chimeric antigen receptor (CAR) T cell
-
Seattle, WashingtonSeattle Children's Hospital
Dec 14, 2022
Fallopian Tube Carcinosarcoma, Primary Peritoneal Carcinosarcoma, Recurrent Fallopian Tube Carcinoma Trial in Rochester (Biopsy,
Not yet recruiting
- Fallopian Tube Carcinosarcoma
- +14 more
- Biopsy
- +6 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jun 28, 2023
Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma, Recurrent Endometrial Endometrioid
Not yet recruiting
- Recurrent Endometrial Carcinoma
- +8 more
- BET Bromodomain Inhibitor ZEN-3694
- +7 more
- (no location specified)
Jul 15, 2023
Testicular Germ Cell Tumor Trial in Saint-Petersburg (Orchofuniculectomy with simultaneous laparoscopic biopsy of the sentinel
Recruiting
- Testicular Germ Cell Tumor
- Orchofuniculectomy with simultaneous laparoscopic biopsy of the sentinel lymph node using indocyanine green dye with/without methylene blue dye.
- Radiopharmaceutical administration (Technetium/methylene blue)
-
Saint-Petersburg, Russian FederationFederal State Budgetary Institute N.N. Petrov National Medical R
Nov 10, 2023
Breast Cancer, Germ Cell Tumor Trial in Brussels (Ergospirometry)
Not yet recruiting
- Breast Cancer
- Germ Cell Tumor
- Ergospirometry
- (no location specified)
Aug 12, 2022
MiRNA in Detecting Active Germ Cell Tumors in Early Suspected
Recruiting
- Malignant Testicular Germ Cell Tumor
- Non-Interventional Study
-
Los Angeles, California
- +1 more
Sep 28, 2023
Ovarian Clear Cell Carcinoma Trial (Zimberelimab, Metformin Hydrochloride)
Not yet recruiting
- Ovarian Clear Cell Carcinoma
- Zimberelimab
- Metformin Hydrochloride
- (no location specified)
Feb 25, 2023